BIOXCEL THERAPEUTICS INC (BTAI) Stock Income Statement
USA - NASDAQ:BTAI - US09075P2048 - Common Stock
1.74 USD
-0.1 (-5.43%)
1.75 USD
+0.01 (+0.57%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 752.00K | 2.27M | 1.38M | 380.00K | 0 | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | 964.00K | 2.14M | 1.26M | 20.00K | null | |||
| Gross Profit | -212.00K | 123.00K | 120.00K | 360.00K | null | |||
| Operating Expenses | 50.23M | 64.93M | 167.74M | 160.00M | 106.94M | |||
| Research and Development | 29.45M | 30.43M | 84.33M | 91.24M | 52.71M | |||
| Selling, General, and Administrative Expenses | 20.79M | 34.49M | 83.41M | 68.76M | 54.23M | |||
| Operating Income | -50.45M | -64.80M | -167.62M | -159.65M | -106.94M | |||
| Interest Income/Expense | -15.51M | -12.53M | -7.67M | -5.69M | 0 | |||
| Other Income/Expense | -2.03M | 20.17M | 394.00K | -430.00K | null | |||
| Non Recurring Items | null | -2.44M | -4.16M | null | null | |||
| Income Before Taxes | -68.21M | -59.60M | -179.05M | -165.76M | -106.93M | |||
| Income Tax | null | null | null | null | null | |||
| Net Income | -68.21M | -59.60M | -179.05M | -165.76M | -106.93M | |||
| EBITDA | -50.14M | -64.50M | -167.30M | -159.32M | -106.64M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -10.408 | -23.5105 | -98.3504 | -94.66 | -64.87 | |||
| Non GAAP EPS | -9.700000000000001 | -25.97 | -98.4 | -94.592 | -65.28 | |||
| Statistics | ||||||||
| Gross Profit Margin | -28.19% | 5.43% | 8.70% | 94.74% | N/A | |||
| Profit Margin | -9070.61% | -2630.14% | -12974.86% | -43621.05% | N/A | |||
| Operating Profit Margin | -6708.24% | -2859.84% | -12146.30% | -42013.16% | N/A | |||
All data in USD